Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 March 2024 | Story Anthony Mthembu | Photo Lutendo Mabata
Prof Nompumelelo Zondi
Prof Nompumelelo Zondi, the newly appointed Vice-Dean: Research and Postgraduate Studies in the Faculty of The Humanities at the University of the Free State (UFS).

Prof Nompumelelo Zondi has been appointed as Vice-Dean: Research and Postgraduate Studies in the Faculty of The Humanities at the University of the Free State (UFS). Prof Zondi assumed this new role on 1 March 2024 after serving as the Head of Department for African Languages at the University of Pretoria for seven years. “I consider this appointment as an opportunity of growth and learning more about higher education and the Faculty of The Humanities at large,” she said.

Prof Zondi indicates that part of her role is to spearhead the UFS Vision130 within the Faculty of The Humanities, and to ensure that the faculty assists the institution in becoming research-led, student-centred, and globally impactful. 

Motivation for assuming this role

One of the primary reasons that led her to consider this role is sharing the knowledge she acquired as part of the Fulbright South African Research Scholar Programme. As a result of that experience and exposure, which went beyond the Ohio State University, she felt it befitting to implement some of the insights she acquired on a bigger scale. Therefore, even though she was impactful in her previous role, Prof Zondi believes that this is an exceptional and more desirable platform to do so. “I feel that I will have easier access to departments within the faculty, while also encouraging and supporting interdepartmental and faculty collaborations,” she explained.

A significant component of Vision 130

He believes that the elements that make up Vision 130 are interrelated. While she considers research central to Vision 130 – as she begins her journey at the UFS, she feels students deserve to be nurtured to further contribute to the university’s impactful research. Thus, student-centredness is the way to go. “I believe that students must be major role players in this Vision130; we must include them in the interactions and discussions that are part of the university’s strategic plan as well as in decision-making processes,” she said. As such, according to Prof Zondi, the more the faculty and the institution care for the students and involve them in Vision130 and in collaborations, the more research outputs the university will achieve. 

News Archive

Researchers receive study grant for research into Congo Fever
2015-03-10

UFS researchers will be contributing significantly to the search for a vaccine against the deadly tick-borne disease known as Congo Fever.

Prof Felicity Burt from the Department of Medical Microbiology and Virology was recently awarded a research grant by the National Health Laboratory Service (NHLS) to study candidate vaccines for Crimean-Congo heamorrhagic fever (CCHF) virus and other arboviruses.

Arboviruses are viruses transmitted by mosquitoes, ticks, or other arthropods.

Prof Burt is an internationally-recognised expert on the Crimean-Congo haemorrhagic fever (CCHF). The Crimean-Congo haemorrhagic fever (CCHF) virus is a tick-borne virus that is associated with severe haemorrhagic disease in South Africa and other parts of Africa, Asia, and eastern Europe. Her interests focus on medically significant viruses that are transmitted by ticks and mosquitoes. Her research group is involved in determining the immune responses that are induced by different viral proteins.

Crimean-Congo haemorrhagic fever (CCHF) virus, a tick- borne virus found in Africa, Asia, the Balkans, and eastern Europe, causes severe viral haemorrhagic fever outbreaks.

Although a number of tick species are capable of becoming infected with CCHF virus, ticks of the genus Hyalomma, commonly referred to in SA as the “bont-legged ticks”, are the principal vector. The ticks have distinctive brown and white bands on their legs.

In February 1981, the first case of CCHF was recognised in South Africa (SA). To date, there have been nearly 200 cases of CCHF infection in SA with a 20% fatality rate. The majority of cases occurring in SA were in patients from the Northern Cape and Free State provinces.

“The funding that has been awarded will be used to profile immune responses against CCHF viral proteins, and investigate mechanisms and strategies to enhance these immune responses. We hope that the study will contribute knowledge towards the development of a vaccine against this medically significant virus.”

For more information or enquiries contact news@ufs.ac.za.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept